IARTIntegra LifeSciences Holdings Corporation
15.56USD-4.66%Mkt Cap: 1.21B USDP/E: Last update: 2026-06-01

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operate…

Indicators:|

Key Statistics

Company
Market Cap1.21B USD
Enterprise Value3.02B USD
Revenue (TTM)1.64B USD
Gross Profit831.62M USD
Net Income (TTM)-516.47M USD
Revenue/Share21.41 USD
Last Price15.56 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4.4K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS4579852082
Valuation
P/E (Trailing)
P/E (Forward)6.14
PEG0.67
EV/EBITDA9.81
EV/Revenue1.84
P/S0.76
P/B1.20
EPS (TTM)-6.47
EPS (Forward)2.61
52W Range
8.70086% of range16.70
52W High16.70 USD
52W Low8.700 USD
Profitability
Gross Margin50.86%
Oper. Margin10.41%
EBITDA Margin18.75%
Profit Margin-31.58%
ROE-49.50%
ROA-14.34%
Growth
Revenue Growth2.40%
Earnings Growth
Cash Flow & Leverage
Operating CF50.38M USD
CapEx (TTM)95.64M USD
FCF Margin4.21%
FCF Yield5.73%
Net Debt1.78B USD
Net Debt/EBITDA5.76
Balance Sheet
Debt/Equity1.95
Current Ratio3.38
Quick Ratio1.53
Book Value/Sh13.39 USD
Cash/Share3.413 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split2:1
Split DateJan 4, 2017
Analyst Consensus
Rating2.9 (Hold)
Target (Mean)17.43 USD
Target Range11.00 USD27.00 USD
# Analysts7
Ownership
Shares Out.77.80M
Float58.69M
Insiders14.41%
Institutions101.08%
Short Interest
Short Ratio8.1d
Short % Float16.31%
Short % Out.11.83%
Shares Short9.20M
Short (prev mo.)9.16M
Technical
SMA 5011.55 (+34.7%)
SMA 20012.58 (+23.7%)
Beta1.08
S&P 52W Chg27.94%
Avg Vol (30d)1.01M
Avg Vol (10d)961.91K
Technical Indicators
RSI (14)74.0
MACD1.2245
MACD Signal1.1246
MACD Hist.+0.0999
BB Upper17.12 USD
BB Middle14.23 USD
BB Lower11.34 USD
BB Width40.63%
ATR (14)0.8260 USD
Vol Ratio (20d)0.29x